Comments
Dr Reddy’s Laboratories on Monday, announced the launch of Sodium Nitroprusside injection, 50 mg/2 ml (25 mg/ml) single-dose vial,in the United States. The Nitropress brand and generics had US sales of about $8 million MAT for the most recent 12 months ended October 2019 according to IQVIA Health. Dr Reddy’s Sodium Nitroprusside injection is available in single-dose 50 mg/2 ml (25 mg/ml) vials. Nitropress is a trademark of Hospira, Inc. Shares of Dr Reddy’s may react positively to the development.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.